Our CEO, Rutger Zietsma, with our Non-Executive Director, Keith Redpath, represented Manus Neurodynamica at MEDICA 2019, which took place on November 18-21 in Düsseldorf, Germany, at the Scottish Enterprise pavilion. MEDICA is known as the world leading trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics. It attracts … Read more
Manus Neurodynamica held an opinion leader advisory group (OLAG) meeting at the International Congress and Parkinson’s Disease and Movement Disorders that took place at the Acropolis Centre in Nice, France, on September 22-26, 2019. The conference, organized by the Movement Disorder Society (MDS), is an annual educational forum for … Read more
European Neurology conference in Valencia – The NeuroMotor Pen – an easily performed objective test of fine motor skill to support diagnosing Parkinson’s disease.
Name:Roman Bauer1, Rutger Zietsma1, Antti Tolonen2, Luc Cluitmans2, Mark van Gils2, Keith Gray3, Richard Walker3 1. Manus Neurodynamica Ltd, Edinburgh, UK 2. Technical Research Centre of Finland (VTT), Tampere, Finland 3. Northumbria Healthcare NHS Foundation Trust, North Shields, UK An easily performed and objective test of fine motor skills would … Read more
SBRI Healthcare Development Contract for Parkinson’s diagnostic pen for GPs MANUS Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces it has received an SBRI Healthcare Development Contract to develop its Parkinson’s disease diagnostic for the GP market. Manus will work with clinicians and … Read more